Antimicrobial therapy as a part of the decontamination procedures for patients with acute leukemia.
D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001414:Bacitracin / Q000627:therapeutic use; D001772:Blood Cell Count; D001792:Blood Platelets; D004203:Disinfection; D004338:Drug Combinations; D005334:Fever; D005856:Germ-Free Life; D005947:Glucose / Q000378:metabolism; D006590:Hexetidine / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000378:metabolism / Q000652:urine; D009355:Neomycin / Q000627:therapeutic use; D009503:Neutropenia; D009761:Nystatin / Q000627:therapeutic use; D010357:Patient Isolators; D011014:Pneumonia / Q000453:epidemiology; D012075:Remission, Spontaneous; D012141:Respiratory Tract Infections / Q000453:epidemiology; D013242:Sterilization; D013916:Thrombelastography; D013997:Time Factors; D014994:Xylose / Q000378:metabolism / Q000652:urine
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D009761:Nystatin; D001414:Bacitracin; D006590:Hexetidine; D014994:Xylose; D009355:Neomycin; D005947:Glucose